163 related articles for article (PubMed ID: 14640915)
1. Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary.
Orbach D; Brisse H; Helfre S; Freneaux P; Husseini K; Aerts I; Desjardins L; Fattet S
Expert Opin Pharmacother; 2003 Dec; 4(12):2165-74. PubMed ID: 14640915
[TBL] [Abstract][Full Text] [Related]
2. Orbital rhabdomyosarcoma: improved survival with combined pulsed chemotherapy and irradiation.
Ghafoor SY; Dudgeon J
Br J Ophthalmol; 1985 Aug; 69(8):557-61. PubMed ID: 3839411
[TBL] [Abstract][Full Text] [Related]
3. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
[TBL] [Abstract][Full Text] [Related]
5. The treatment of orbital rhabdomyosarcoma with irradiation and chemotherapy.
Abramson DH; Ellsworth RM; Tretter P; Wolff JA; Kitchin FD
Ophthalmology; 1979 Jul; 86(7):1330-5. PubMed ID: 233865
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
Gandhi PD; Fleming JC; Haik BG; Wilson MW
Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
[TBL] [Abstract][Full Text] [Related]
7. [Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Olivier Pascual N; Calvo JM; Abelairas Gómez JM
Arch Soc Esp Oftalmol; 2005 Jun; 80(6):331-8. PubMed ID: 15986273
[TBL] [Abstract][Full Text] [Related]
8. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop.
Oberlin O; Rey A; Anderson J; Carli M; Raney RB; Treuner J; Stevens MC;
J Clin Oncol; 2001 Jan; 19(1):197-204. PubMed ID: 11134213
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
[TBL] [Abstract][Full Text] [Related]
10. Optimal management strategies for rhabdomyosarcoma in children.
Walterhouse D; Watson A
Paediatr Drugs; 2007; 9(6):391-400. PubMed ID: 18052409
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma.
Paulino AC; Simon JH; Zhen W; Wen BC
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1489-95. PubMed ID: 11121653
[TBL] [Abstract][Full Text] [Related]
12. What is new in rhabdomyosarcoma management in children?
Gosiengfiao Y; Reichek J; Walterhouse D
Paediatr Drugs; 2012 Dec; 14(6):389-400. PubMed ID: 23050743
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of orbital rhabdomyosarcoma in two infants using chemotherapy alone.
Lackner H; Urban C
Med Pediatr Oncol; 1997 Jun; 28(6):463-4. PubMed ID: 9143395
[No Abstract] [Full Text] [Related]
14. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results.
Flamant F; Rodary C; Voute PA; Otten J
Radiother Oncol; 1985 Apr; 3(3):227-36. PubMed ID: 3890032
[TBL] [Abstract][Full Text] [Related]
15. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
[TBL] [Abstract][Full Text] [Related]
16. Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study.
Heyn R; Ragab A; Raney RB; Ruymann F; Tefft M; Lawrence W; Soule E; Maurer HM
Cancer; 1986 May; 57(9):1738-43. PubMed ID: 3955518
[TBL] [Abstract][Full Text] [Related]
17. Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.
Smith SC; Lindsley SK; Felgenhauer J; Hawkins DS; Douglas JG
J Pediatr Hematol Oncol; 2003 Oct; 25(10):774-9. PubMed ID: 14528099
[TBL] [Abstract][Full Text] [Related]
18. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
19. Management of orbital rhabdomyosarcoma.
Dayton GO; Langdon E; Rochlin D
Trans Pac Coast Otoophthalmol Soc Annu Meet; 1969; 50():225-36. PubMed ID: 4924570
[No Abstract] [Full Text] [Related]
20. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.
Rousseau P; Flamant F; Quintana E; Voute PA; Gentet JC
J Clin Oncol; 1994 Mar; 12(3):516-21. PubMed ID: 7509854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
